Dr Oliver Segal in The Times - X-Vert trial

Dr Oliver Segal is quoted in the Times newspaper for his reaction on the exciting news from the Rivaroxaban X-Vert trial – the first randomised prospective confirming the safety and efficacy of using Rivaroxaban (a novel anticoagulant) for patients undergoing electrical cardioversion (shock treatment) for atrial fibrillation.





















Latest news

The Private Clinic launches exciting new non-invasive cosmetic treatments for 2020

Andrew Goldberg was featured on Radio 4's 'Inside Health'.

Mr Ravi Ratnavel publishes skin surgery patient advice leaflet

Dr Oliver Segal in The Times - X-Vert trial

Cardiologist (Adult)

London, SE1 2PR

020 703... 020 7034 8278 reveal tel

25 Year(s)
GP referral
Not Required